Abiomed acquires precardia, a breakthrough medical device company, to improve outcomes for heart failure patients

Danvers, mass.--(business wire)--abiomed (nasdaq: abmd) has acquired precardia, developer of a proprietary catheter and controller that will complement abiomed's product portfolio to expand options for patients with acute decompensated heart failure (adhf). the precardia system is uniquely designed to rapidly treat adhf-related volume overload by effectively reducing cardiac filling pressures and promoting decongestion to improve overall cardiac and renal function. annually, more than one milli
ABMD Ratings Summary
ABMD Quant Ranking